Ronald Thure Wester

USPTO Granted Patents = 30 (Patent Applications = 7)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 4.1

ph-index = 13

Forward Citations = 501(Granted Patents)

Location History:

Mystic, CT (US) (1989 - 1991)
Ledyard, CT (US) (1994 - 2022)

Company Filing History:

Nimbus Lakshimi, Inc.

patents

5. 1 out of 2,538

Warner-lambert Company

patents

6. 1 out of 2,882

The General Hospital Corporation

patents

7. 1 out of 123

Institut National De La Recherche Scientifique

patents

where one patent can have more than one assignee

Years Active: 1989-2022

Loading Chart...

30 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11434240 - TYK2 inhibitors and uses thereof (2022-09-06),

2. 10968236 - TYK2 inhibitors and uses thereof (2021-04-06),

3. 10781204 - TYK2 inhibitors and uses thereof (2020-09-22),

4. 10253046 - TYK2 inhibitors and uses thereof (2019-04-09),

5. 10196390 - TYK2 inhibitors and uses thereof (2019-02-05),

6. 10023571 - TYK2 inhibitors and uses thereof (2018-07-17),

7. 9751892 - IRAK inhibitors and uses thereof (2017-09-05),

8. 9643933 - Compounds useful as antibiotic tolerance inhibitors (2017-05-09),

9. 9630970 - TYK2 inhibitors and uses thereof (2017-04-25),

10. 9340540 - TYK2 inhibitors and uses thereof (2016-05-17),

11. 9212190 - IRAK inhibitors and uses thereof (2015-12-15),

12. 9175007 - IRAK inhibitors and uses thereof (2015-11-03),

13. 9067948 - IRAK inhibitors and uses thereof (2015-06-30),

14. 6974813 - N-[(substituted five-membered di-or triaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia (2005-12-13),

15. 6906082 - 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines (2005-06-14),

Title: Spotlight on Inventor Ronald Thure Wester from Ledyard, US

Introduction:

Ronald Thure Wester, hailing from Ledyard, CT (US), is a prolific inventor with an impressive portfolio of 30 patents. His innovative spirit and dedication to pushing the boundaries of science and technology have paved the way for groundbreaking developments in various fields.

Latest Patents:

Among Ronald Thure Wester's latest patents is the revolutionary invention of TYK2 inhibitors and their uses. These compounds of formula I, along with their compositions and methods, demonstrate remarkable potential for inhibiting TYK2 and treating TYK2-mediated disorders. This cutting-edge technology showcases Wester's commitment to advancing medical research and improving healthcare outcomes.

Career Highlights:

Throughout his career, Ronald Thure Wester has made significant contributions to the pharmaceutical industry. He has held key positions at reputable organizations such as Pfizer Corporation and Nimbus Lakshmi, Inc., where his expertise and innovative mindset have been instrumental in driving progress and fostering innovation. Wester's role in developing novel solutions underscores his profound impact on the field of life sciences.

Collaborations:

In his professional journey, Ronald Thure Wester has collaborated with accomplished individuals like Roger B Ruggeri and Craig E. Masse. Together, they have synergized their talents and expertise to create groundbreaking technologies and drive forward-thinking initiatives. The collaborations reflect Wester's collaborative spirit and his ability to thrive in team environments.

Conclusion:

In conclusion, Ronald Thure Wester stands as a visionary inventor who continues to leave an indelible mark on the world of innovation. His remarkable achievements, coupled with his relentless pursuit of excellence, highlight his significance in shaping the landscape of inventions and patents. Wester's dedication to advancing scientific knowledge and improving human well-being serves as an inspiration to aspiring inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.